GLUT-1 expression is largely unrelated to both hypoxia and the Warburg phenotype in squamous cell carcinomas of the vulva

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Mayer, Arnulf ^a   Schmidt, Marcus ^a   Seeger, Alexander ^a   Serras, André Franke ^a   Vaupel, Peter ^a   Schmidberger, Heinz ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Carbonic anhydrase IX; Glucose transporter; Hexokinase 2; Hypoxia; Pyruvate kinase M2; Vulvar carcinoma; Warburg effect

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; CARBONATE DEHYDRATASE IX; CD34 ANTIGEN; GLUCOSE TRANSPORTER 1; HEXOKINASE; HEXOKINASE 2; KI 67 ANTIGEN; PYRUVATE KINASE; PYRUVATE KINASE M2; UNCLASSIFIED DRUG; CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE; TUMOR ANTIGEN;

AEROBIC GLYCOLYSIS; ARTICLE; CELL AGGREGATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME LOCALIZATION; FEMALE; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; PATHOPHYSIOLOGY; PHENOTYPE; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; STROMA; TUMOR CELL; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VASCULARIZATION; VULVA CARCINOMA; VULVA DISEASE; VULVAR DYSPLASIA; WARBURG EFFECT; ANOXIA; GENE EXPRESSION; GENETICS; METABOLISM; MICROVASCULATURE; PATHOLOGY; VULVA TUMOR;

ANOXIA; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CARBONIC ANHYDRASES; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MICROVESSELS; NEOPLASM RECURRENCE, LOCAL; PHENOTYPE; VULVAR NEOPLASMS;

EID: 84929940663     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-760     Document Type: Article

References (31)

1. Vaupel P: Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 2004, 14:198-206.
2. Warburg O: On the origin of cancer cells. Science 1956, 123:309-314.
3. Hirschhaeuser F, Sattler UG, Mueller-Klieser W: Lactate: a metabolic key player in cancer. Cancer Res 2011, 71:6921-6925.
4. Potter CP, Harris AL: Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br J Cancer 2003, 89:2-7.
5. Rademakers SE, Lok J, van der Kogel AJ, Bussink J, Kaanders JH: Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1alpha, CAIX, LDH-5, GLUT-1, MCT1 and MCT4. BMC Cancer 2011, 11:167.
6. Airley RE, Loncaster J, Raleigh JA, Harris AL, Davidson SE, Hunter RD, West CM, Stratford IJ: GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int J Cancer 2003, 104:85-91.
7. Mayer A, Schneider F, Vaupel P, Sommer C, Schmidberger H: Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma. Int J Oncol 2012, 41:1260-1270.
8. Mayer A, Vaupel P: Hypoxia markers and their clinical relevance. In Tumor Hypoxia in the Clinical Setting. Edited by Osinsky S, Friess H, Vaupel P. Kiev, Ukraine: Akademperiodyka; 2011:187-202.
9. Gatenby RA, Gillies RJ: Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004, 4:891-899.
10. Sattler UG, Meyer SS, Quennet V, Hoerner C, Knoerzer H, Fabian C, Yaromina A, Zips D, Walenta S, Baumann M, Mueller-Klieser W: Glycolytic metabolism and tumour response to fractionated irradiation. Radiother Oncol 2010, 94:102-109.
11. Zhou M, Zhao Y, Ding Y, Liu H, Liu Z, Fodstad O, Riker AI, Kamarajugadda S, Lu J, Owen LB, Ledoux SP, Tan M: Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer 2010, 9:33.
12. Fast Stats: an interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute. http://seer. cancer.gov/faststats. (Accessed on 1-28-2014).
13. Vaupel P, Mayer A, Höckel M: Oxygenation status of primary and recurrent squamous cell carcinomas of the vulva. Eur J Gynaecol Oncol 2006, 27:142-146.
14. Stone JE, Parker R, Gilks CB, Stanbridge EJ, Liao SY, Aquino-Parsons C: Intratumoral oxygenation of invasive squamous cell carcimoma of the vulva is not correlated with regional lymph node metastasis. Eur J Gynaecol Oncol 2005, 26:31-35.
15. Pedersen PL: Warburg, me and Hexokinase 2: multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr 2007, 39:211-222.
16. Vander Heiden MG, Locasale JW, Swanson KD, Sharfi H, Heffron GJ, Amador-Noguez D, Christofk HR, Wagner G, Rabinowitz JD, Asara JM, Cantley LC: Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 2010, 329:1492-1499.
17. Arganda-Carreras I, Sorzano COS, Marabini R, Carazo JM, Ortiz-De-Solorzano C, Kybic J: Consistent and elastic registration of histological sections using vector-spline regularization. Comput Vis Approaches Med Image Anal 2006, 4241:85-95.
18. Schneider CA, Rasband WS, Eliceiri KW: NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012, 9:671-675.
19. "Landmark Correspondences" [ImageJ Plugin]. http://fiji.sc/ Landmark_Correspondences (accessed 08/18/2014).
20. Mayer A, Höckel M, Vaupel P: Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally advanced cancers of the uterine cervix. Clin Cancer Res 2005, 11:7220-7225.
21. Mayer A, Höckel M, Wree A, Vaupel P: Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers. Clin Cancer Res 2005, 11:2768-2773.
22. Jankovic B, Aquino-Parsons C, Raleigh JA, Stanbridge EJ, Durand RE, Banath JP, MacPhail SH, Olive PL: Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix. Cytometry B Clin Cytom 2006, 70:45-55.
23. Iakovlev VV, Pintilie M, Morrison A, Fyles AW, Hill RP, Hedley DW: Effect of distributional heterogeneity on the analysis of tumor hypoxia based on carbonic anhydrase IX. Lab Invest 2007, 87:1206-1217.
24. van de Nieuwenhof HP, de Hullu JA, Kaanders JH, Bulten J, Massuger LF, van Kempen LC: Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue. Virchows Arch 2010, 457:693-703.
25. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, Wernerus H, Bjorling L, Ponten F: Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 2010, 28:1248-1250.
26. Li YZ, Li SL, Li X, Wang LJ, Wang JL, Xu JW, Wu ZH, Gong L, Zhang XD: Expression of endogenous hypoxia markers in vulvar squamous cell carcinoma. Asian Pac J Cancer Prev 2012, 13:3675-3680.
27. Choschzick M, Woelber L, Hess S, Zu Eulenburg C, Schwarz J, Simon R, Mahner S, Jaenicke F, Muller V: Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases. Virchows Arch 2010, 456:483-490.
28. Tannock IF: The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer 1968, 22:258-273.
29. Lu H, Forbes RA, Verma A: Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 2002, 277:23111-23115.
30. Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC, Xavier RJ: An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res 2009, 37:4587-4602.
31. Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, Kaanders JH, van der Kogel AJ, Riggins GJ: Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 2001, 93:1337-1343.